<?xml version="1.0" encoding="UTF-8"?>
<p>The presented evidence attests to the immediate need for prioritizing LRD populations in HCV testing and treatment programs. Recent evidence has also highlighted the program efficiency of this prioritization.
 <xref rid="hep41491-bib-0053" ref-type="ref">53</xref>, 
 <xref rid="hep41491-bib-0054" ref-type="ref">54</xref> It is also clear that interventions, such as testing and treatment, have not yet reached sufficient effectiveness, coverage, and reach to impact HCV epidemiology (apart from Egypt). Without timely and effective interventions, elimination of HCV infection and its disease burden by 2030 will not be possible.
</p>
